Catalyst Wire Dossier Catalyst Wire Dossier

Buprenorphine/Naltrexone

buprenorphine and naltrexone · National Institute on Drug Abuse (NIDA)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Buprenorphine/Naltrexone, covering 2017-01-12 to 2017-01-12. Get the full timeline:

Most recent: Clinical Trial Update: Buprenorphine Naltrexone-P1 A-Cocaine [Phase 1]

See pricing